WO2000072829A1 - Novel formulations comprising lipid-regulating agents - Google Patents
Novel formulations comprising lipid-regulating agents Download PDFInfo
- Publication number
- WO2000072829A1 WO2000072829A1 PCT/US2000/014109 US0014109W WO0072829A1 WO 2000072829 A1 WO2000072829 A1 WO 2000072829A1 US 0014109 W US0014109 W US 0014109W WO 0072829 A1 WO0072829 A1 WO 0072829A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- lipid
- excipient
- fenofibrate
- regulating agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MXPA01012225A MXPA01012225A (en) | 1999-05-28 | 2000-05-23 | Novel formulations comprising lipid-regulating agents. |
CA002374117A CA2374117A1 (en) | 1999-05-28 | 2000-05-23 | Novel formulations comprising lipid-regulating agents |
EP00937680A EP1183017A1 (en) | 1999-05-28 | 2000-05-23 | Novel formulations comprising lipid-regulating agents |
JP2000620941A JP2003500439A (en) | 1999-05-28 | 2000-05-23 | New formulations containing lipid regulators |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32318399A | 1999-05-28 | 1999-05-28 | |
US09/323,183 | 1999-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000072829A1 true WO2000072829A1 (en) | 2000-12-07 |
Family
ID=23258077
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/014109 WO2000072829A1 (en) | 1999-05-28 | 2000-05-23 | Novel formulations comprising lipid-regulating agents |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1183017A1 (en) |
JP (1) | JP2003500439A (en) |
CA (1) | CA2374117A1 (en) |
MX (1) | MXPA01012225A (en) |
WO (1) | WO2000072829A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2441499A (en) * | 2006-09-08 | 2008-03-12 | Jasin El Sammadoni | A slimming spray |
US7927627B2 (en) | 2002-05-24 | 2011-04-19 | Elan Pharma International, Ltd. | Nanoparticulate fibrate formulations |
EP2601935A1 (en) | 2007-09-25 | 2013-06-12 | Solubest Ltd. | Compositions comprising lipophilic active compounds and method for their preparation |
US8722094B2 (en) | 2008-03-11 | 2014-05-13 | Aska Pharmaceutical Co., Ltd. | Solid dispersion and pharmaceutical composition of the same, and production processes thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101299707B1 (en) * | 2004-05-14 | 2013-08-28 | 에미스페어 테크놀로지스, 인코포레이티드 | Compounds and compositions for delivering active agents |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2157201A1 (en) * | 1970-11-13 | 1973-05-30 | Boehringer Mannheim Gmbh | Oral application forms of raubasine-contg polyethylene - glycol and an organic acid |
US4957746A (en) * | 1984-06-29 | 1990-09-18 | Roberto Valducci | Process for preparing etofibrate or similar compounds containing sustained release microgranules and products thus obtained |
WO1993011749A1 (en) * | 1991-12-18 | 1993-06-24 | Warner-Lambert Company | A process for the preparation of a solid dispersion |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2627696B1 (en) * | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | NEW GALENIC FORM OF FENOFIBRATE |
-
2000
- 2000-05-23 EP EP00937680A patent/EP1183017A1/en not_active Withdrawn
- 2000-05-23 JP JP2000620941A patent/JP2003500439A/en not_active Withdrawn
- 2000-05-23 WO PCT/US2000/014109 patent/WO2000072829A1/en not_active Application Discontinuation
- 2000-05-23 CA CA002374117A patent/CA2374117A1/en not_active Abandoned
- 2000-05-23 MX MXPA01012225A patent/MXPA01012225A/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2157201A1 (en) * | 1970-11-13 | 1973-05-30 | Boehringer Mannheim Gmbh | Oral application forms of raubasine-contg polyethylene - glycol and an organic acid |
US4957746A (en) * | 1984-06-29 | 1990-09-18 | Roberto Valducci | Process for preparing etofibrate or similar compounds containing sustained release microgranules and products thus obtained |
WO1993011749A1 (en) * | 1991-12-18 | 1993-06-24 | Warner-Lambert Company | A process for the preparation of a solid dispersion |
Non-Patent Citations (3)
Title |
---|
MARGARIT MARIA VICTORIA ET AL: "Physical characteristics and dissolution kinetics of solid dispersions of ketoprofen and polyethylene glycol 6000.", INTERNATIONAL JOURNAL OF PHARMACEUTICS (AMSTERDAM), vol. 108, no. 2, 1994, pages 101 - 107, XP000929782, ISSN: 0378-5173 * |
See also references of EP1183017A1 * |
SHEU ET AL: "Characterization and dissolution of fenofibrate solid dispersion systems", INTERNATIONAL JOURNAL OF PHARMACEUTICS,NL,AMSTERDAM, vol. 103, no. 2, 1994, pages 137 - 146, XP002091325, ISSN: 0378-5173 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7927627B2 (en) | 2002-05-24 | 2011-04-19 | Elan Pharma International, Ltd. | Nanoparticulate fibrate formulations |
US7931917B2 (en) | 2002-05-24 | 2011-04-26 | Elan Pharma International, Ltd. | Nanoparticulate fibrate formulations |
GB2441499A (en) * | 2006-09-08 | 2008-03-12 | Jasin El Sammadoni | A slimming spray |
GB2441499B (en) * | 2006-09-08 | 2011-09-14 | Jasin El Sammadoni | Slimming Spray |
EP2601935A1 (en) | 2007-09-25 | 2013-06-12 | Solubest Ltd. | Compositions comprising lipophilic active compounds and method for their preparation |
US9254268B2 (en) | 2007-09-25 | 2016-02-09 | Solubest Ltd. | Compositions comprising lipophilic active compounds and method for their preparation |
US8722094B2 (en) | 2008-03-11 | 2014-05-13 | Aska Pharmaceutical Co., Ltd. | Solid dispersion and pharmaceutical composition of the same, and production processes thereof |
Also Published As
Publication number | Publication date |
---|---|
CA2374117A1 (en) | 2000-12-07 |
JP2003500439A (en) | 2003-01-07 |
EP1183017A1 (en) | 2002-03-06 |
MXPA01012225A (en) | 2002-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6465011B2 (en) | Formulations comprising lipid-regulating agents | |
US6372251B2 (en) | Formulations comprising lipid-regulating agents | |
US4404183A (en) | Sustained release pharmaceutical composition of solid medical material | |
JP5560188B2 (en) | New process for producing water-dispersible dry pharmaceutical product and pharmaceutical composition obtained thereby | |
US6368622B2 (en) | Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption | |
EP1162954A1 (en) | Novel formulations comprising lipid-regulating agents | |
US6383517B1 (en) | Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption | |
MX2007012124A (en) | Formulations containing fenofibrate and surfacant mixture. | |
EP1140036A2 (en) | Novel formulations comprising lipid-regulating agents | |
US6838091B2 (en) | Formulations comprising lipid-regulating agents | |
CA2367995A1 (en) | Novel formulations comprising lipid-regulating agents | |
US6719999B2 (en) | Formulations comprising lipid-regulating agents | |
US6814977B1 (en) | Formulations comprising lipid-regulating agents | |
US8062664B2 (en) | Process for preparing formulations of lipid-regulating drugs | |
WO2000072829A1 (en) | Novel formulations comprising lipid-regulating agents | |
US20020040046A1 (en) | Novel formulations comprising lipid-regulating agents | |
US7014864B1 (en) | Formulations comprising lipid-regulating agents | |
CA2531097C (en) | Process for preparing formulations of lipid-regulating drugs | |
US20060177512A1 (en) | Process for preparing formulations of lipid-regulating drugs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP MX |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2374117 Country of ref document: CA Ref country code: CA Ref document number: 2374117 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 620941 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/012225 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000937680 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000937680 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000937680 Country of ref document: EP |